PMID: 11927840Apr 3, 2002Paper

Variation in coumarin 7-hydroxylase activity associated with genetic polymorphism of cytochrome P450 2A6 and the body status of iron stores in adult Thai males and females

Pharmacogenetics
Pailin UjjinT Kamataki

Abstract

The relationships between catalytic activity of cytochrome P450 2A6 (CYP2A6), polymorphism of CYP2A6 gene, gender and levels of body iron stores were analysed in a sample group of 202 apparently healthy Thais, aged 19-47 years. Eleven individuals were found to have high activity of CYP2A6, judged by the relatively large amounts (11.2-14.6 mg) of 7-hydroyxcoumarin (7-OHC) excreted 3 h following administration of 15 mg of coumarin. Ten individuals, however, did not excrete any 7-OHC. Of these 10, four were found to have no CYP2A6 gene (whole gene deletion; CYP2A6*4 allele). The frequency of the CYP2A6 alleles; *1A, *1B and *4 in the whole sample group was 52, 40 and 8% while the frequency of the CYP2A6 gene types; *1A/*1A, *1A/*1B, *1B/*1B, *1A/*4, *1B/*4, *4/*4 was 29, 41, 16, 7, 5 and 2%. Subjects having CYP2A6*1A/*1B gene-type group were found to have higher rates of coumarin 7-hydroxylation compared with those of the CYP2A6*1B/*1B and CYP2A6*1A/*4 gene types. The inter-individual variability in CYP2A6 catalytic activity was therefore attributed in part to the CYP2A6 genetic polymorphism. Variation in CYP2A6 activity in this sample group was not associated with gender but, interestingly, it did show an inverse association with...Continue Reading

References

Jan 1, 1991·European Journal of Clinical Pharmacology·H KraulA Hoffmann
Jan 1, 1985·British Journal of Clinical Pharmacology·O PelkonenJ T Ahokas
Dec 1, 1994·Environmental Health Perspectives·M BerglundM Vahter
Nov 15, 1994·International Journal of Cancer. Journal International Du Cancer·M R Haswell-ElkinsD B Elkins
Jan 1, 1994·Journal of Cancer Research and Clinical Oncology·O PelkonenJ Hakkola
Feb 1, 1996·Toxicology and Applied Pharmacology·M VahterA Akesson
Jan 1, 1996·Journal of Gastroenterology and Hepatology·J GeorgeG C Farrell
May 1, 1996·Environmental Health Perspectives·H Bartsch, E Hietanen
Oct 1, 1996·Journal of Pharmacokinetics and Biopharmaceutics·S A WrightonB J Ring
Nov 14, 1997·Toxicology·M PasanenA Rautio
Aug 26, 1998·Drug Metabolism Reviews·C A Mugford, G L Kedderis
Apr 13, 1999·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·C Ioannides
Jun 3, 1999·Biochemical Pharmacology·S KoskelaH Raunio
Aug 12, 1999·Biochemical and Biophysical Research Communications·M MiyamotoT Kamataki
Oct 13, 1999·Mutation Research·T KamatakiK Fujita
Jan 4, 2001·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·C M DreslerM L Clapper
Mar 10, 2001·Biochemical and Biophysical Research Communications·N AriyoshiT Kamataki
Jul 4, 2001·Pharmacogenetics·J T KwonT Yokoi

❮ Previous
Next ❯

Citations

Nov 4, 2008·European Journal of Clinical Pharmacology·M I VeigaJ P Gil
Dec 17, 2008·European Journal of Clinical Pharmacology·Wiratchanee MahavorasirikulKesara Na-Bangchang
Oct 7, 2009·Environmental Geochemistry and Health·Roongnapa ApinanKesara Na-Bangchang
Sep 23, 2003·Progress in Neuro-psychopharmacology & Biological Psychiatry·Edward F DominoKari S Fedewa
May 7, 2014·Biological Trace Element Research·Byung-Kook LeeYangho Kim
Feb 20, 2004·Human Mutation·Marià PitarqueMagnus Ingelman-Sundberg
Nov 1, 2009·Environmental Toxicology and Pharmacology·Roongnapa ApinanKesara Na-Bangchang
Dec 28, 2005·Biochemical and Biophysical Research Communications·Jue WangMagnus Ingelman-Sundberg
Jan 16, 2007·Drug Metabolism and Pharmacokinetics·Sompop PeamkrasatamKrongtong Yoovathaworn
Dec 25, 2004·Drug Metabolism and Pharmacokinetics·Kazuma KiyotaniTetsuya Kamataki
Dec 17, 2014·Journal of Trace Elements in Medicine and Biology : Organ of the Society for Minerals and Trace Elements (GMS)·Kyoung Sook JeongYangho Kim
Jun 25, 2016·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Na GaoHailing Qiao
Mar 1, 2005·Pharmacological Reviews·Janne HukkanenNeal L Benowitz
Jan 27, 2005·The Journal of Pharmacology and Experimental Therapeutics·Marià PitarqueMagnus Ingelman-Sundberg
Dec 18, 2019·International Journal of Toxicology·ChingYi Jennifer HsiehMartha S Sandy
Jul 25, 2007·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Eriko HigashiMiki Nakajima
Jun 28, 2005·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Miyuki KimuraTetsuya Kamataki
Dec 29, 2019·The Journal of Pharmacology and Experimental Therapeutics·Yan FangHai-Ling Qiao

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.